Exchange: NYSEMkt·Updated 11:40 AM EDT
KAPA logo

KAPA Kairos Pharma Ltd.

$1.75
$0.015
(0.87%)
Today
Mkt Cap$5.86M
Vol15,511.00

About KAPA

Kairos Pharma Ltd. is a clinical-stage biopharmaceutical company, which engages in the development of novel and transformative drug therapies to treat cancer. It focuses on the research and development of immunotherapies for oncology. The company was founded by John S. Yu on June 17, 2013 and is headquartered in Los Angeles, CA.
45

Neutral Sentiment

How do you feel about KAPA?

Advertisement|Remove ads.